Designing an emergency stop switch for immunotherapies

février 2020

CAR T-cell therapy is a highly promising treatment strategy for tumors, but is associated with life-threatening side effects. Researchers at EPFL, UNIL and CHUV have developed a new way to “switch off” the therapy when a cancer patient’s life is in danger, paving the way for safer immunotherapy approaches to target solid tumors.


février 2020

octobre 2019

novembre 2018

octobre 2018

septembre 2018